[1]
|
Kuipers, E.J., Grady, W.M., Lieberman, D., et al. (2015) Colorectal Cancer. Nature Reviews Disease Primers, 1, Article No. 15065. https://doi.org/10.1038/nrdp.2015.65
|
[2]
|
Arnold, M., Sierra, M.S., Laversanne, M., et al. (2017) Global Patterns and Trends in Colorectal Cancer Incidence and Mortality. Gut, 66, 683-691. https://doi.org/10.1136/gutjnl-2015-310912
|
[3]
|
Zhong, Y., Long, T., Gu, C.S., et al. (2021) MYH9-Dependent Polarization of ATG9B Promotes Colorectal Cancer Metastasis by Accelerating Focal Adhesion Assembly. Cell Death & Differentiation, 28, 3251-3269.
https://doi.org/10.1038/s41418-021-00813-z
|
[4]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[5]
|
Faugeras, L., Dili, A., Druez, A., et al. (2017) Treatment Options for Met-astatic Colorectal Cancer in Patients with Liver Dysfunction Due To Malignancy. Critical Reviews in Oncolo-gy/Hematolog, 115, 59-66.
https://doi.org/10.1016/j.critrevonc.2017.03.029
|
[6]
|
Francescone, R., Hou, V. and Grivennikov, S.I. (2015) Cyto-kines, IBD, and Colitis-Associated Cancer. Inflammatory Bowel Diseases, 21, 409-418. https://doi.org/10.1097/MIB.0000000000000236
|
[7]
|
Geng, F., Wang, Z., Yin, H., et al. (2017) Molecular Tar-geted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives. Cancer Biotherapy & Radio-pharmaceuticals, 32, 149-160.
https://doi.org/10.1089/cbr.2017.2210
|
[8]
|
Wang, C.Z., Calway, T. and Yuan, C.S. (2012) Herbal Medicines as Adjuvants for Cancer Therapeutics. The American Journal of Chinese Medicine, 40, 657-669. https://doi.org/10.1142/S0192415X12500498
|
[9]
|
Mao, D., Feng, L., Huang, S., et al. (2019) Meta-Analysis of Xihuang Pill Efficacy When Combined with Chemotherapy for Treatment of Breast Cancer. Evidence-Based Comple-mentary and Alternative Medicine, 2019, Article ID: 3502460. https://doi.org/10.1155/2019/3502460
|
[10]
|
Zhang, Q., Chen, X., Luo, Y., et al. (2017) Fuzi Enhances Anti-Tumor Efficacy of Radiotherapy on Lung Cancer. Journal of Cancer, 8, 3945-3951. https://doi.org/10.7150/jca.22162
|
[11]
|
Yu, C.T., Chen, T., Lu, S., et al. (2022) Identification of Significant Modules and Targets of Xian-Lian-Jie-Du Decoction Based on the Analysis of Transcriptomics, Prote-omics and Single-Cell Transcriptomics in Colorectal Tumor. Journal of Inflammation Research, 15, 1483-1499. https://doi.org/10.2147/JIR.S344861
|
[12]
|
Huang, S., Zhang, Z., Li, W., et al. (2020) Network Pharmacolo-gy-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer. Drug Design, Development and Therapy, 14, 2725-2740. https://doi.org/10.2147/DDDT.S250991
|
[13]
|
Shi, H., Tian, S. and Tian, H. (2021) Network Pharmacology Inter-pretation of Fuzheng-Jiedu Decoction against Colorectal Cancer. Evidence-Based Complementary and Alternative Medi-cine, 2021, Article ID: 4652492.
https://doi.org/10.1155/2021/4652492
|
[14]
|
Jiang, X., Jiang, Z., Jiang, M., et al. (2022) Berberine as a Potential Agent for the Treatment of Colorectal Cancer. Frontiers in Medicine, 9, Article 886996. https://doi.org/10.3389/fmed.2022.886996
|
[15]
|
Xue, X., Zhao, X., Wang, J., et al. (2023) Carthami Flos Extract against Carbon Tetrachloride-Induced Liver Fibrosis via Alleviating Angiogenesis in Mice. Phytomedicine, 108, Article ID: 154517.
https://doi.org/10.1016/j.phymed.2022.154517
|
[16]
|
Li, S.Y., Shi, C.J., Fu, W.M., et al. (2023) Berberine Inhibits Tumour Growth in Vivo and in Vitro through Suppressing the LincROR-Wnt/β-Catenin Regulatory Axis in Colorectal Cancer. Journal of Pharmacy and Pharmacology, 75, 129-138. https://doi.org/10.1093/jpp/rgac067
|
[17]
|
Berger, S.I. and Iyengar, R. (2009) Network Analyses in Systems Pharmacology. Bioinformatics, 25, 2466-2472.
https://doi.org/10.1093/bioinformatics/btp465
|
[18]
|
Zeng, L. and Yang, K. (2017) Exploring the Pharmacological Mechanism of Yanghe Decoction on HER2-Positive Breast Cancer by a Network Pharmacology Approach. Journal of Ethnopharmacology, 199, 68-85.
https://doi.org/10.1016/j.jep.2017.01.045
|
[19]
|
Ritchie, M.E., Phipson, B., Wu, D., et al. (2015) Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies. Nucleic Acids Research, 43, e47. https://doi.org/10.1093/nar/gkv007
|
[20]
|
Gu, Z., Eils, R. and Schlesner, M. (2016) Complex Heatmaps Reveal Pat-terns and Correlations in Multidimensional Genomic Data. Bioinformatics, 32, 2847-2849. https://doi.org/10.1093/bioinformatics/btw313
|
[21]
|
Miao, X., Luo, Q., Zhao, H., et al. (2016) Co-Expression Analysis and Identification of Fecundity-Related Long Non-Coding RNAs in Sheep Ovaries. Scientific Reports, 6, Arti-cle No. 39398. https://doi.org/10.1038/srep39398
|
[22]
|
Jiang, S., Zhang, Q., Su, Y. and Pan, L.Q. (2018) Net-work-Based Differential Analysis to Identify Molecular Features of Tumorigenesis for Esophageal Squamous Carcinoma. Molecules, 23, Article 88.
https://doi.org/10.3390/molecules23010088
|
[23]
|
Berman, H.M., Westbrook, J., Feng, Z., et al. (2000) The Protein Data Bank. Nucleic Acids Research, 28, 235-242.
https://doi.org/10.1093/nar/28.1.235
|
[24]
|
Surget, S., Khoury, M.P. and Bourdon, J.C. (2013) Uncovering the Role of P53 Splice Variants in Human Malignancy: A Clinical Perspective. OncoTargets and Therapy, 7, 57-68. https://doi.org/10.2147/OTT.S53876
|
[25]
|
Ventura, A., Kirsch, D.G., Mclaughlin, M.E., et al. (2007) Restoration of P53 Function Leads to Tumour Regression in Vivo. Nature, 445, 661-665. https://doi.org/10.1038/nature05541
|
[26]
|
Wang, J., Li, Y., Ding, M., et al. (2017) Molecular Mechanisms and Clinical Applications of MiR-22 in Regulating Malignant Progression in Human Cancer (Review). International Journal of Oncology, 50, 345-355.
https://doi.org/10.3892/ijo.2016.3811
|
[27]
|
Ho, K.K., Myatt, S.S. and Lam, E.W. (2008) Many Forks in the Path: Cycling with FoxO. Oncogene, 27, 2300-2311.
https://doi.org/10.1038/onc.2008.23
|
[28]
|
Myatt, S.S. and Lam, E.W. (2007) The Emerging Roles of Forkhead Box (Fox) Proteins in Cancer. Nature Reviews Cancer, 7, 847-859. https://doi.org/10.1038/nrc2223
|
[29]
|
Bernard, R., Getachew, R., Kamato, D., et al. (2016) Evaluation of the Potential Synergism of Imatinib-Related Poly Kinase Inhibitors Using Growth Factor Stimulated Proteoglycan Synthesis as a Model Response. Journal of Pharmacy and Pharmacology, 68, 368-378. https://doi.org/10.1111/jphp.12530
|
[30]
|
Lo, Y.H., Romes, E.M., Pillon, M.C., et al. (2017) Structural Analysis Reveals Features of Ribosome Assembly Factor Nsa1/WDR74 Important for Localization and Interaction with Rix7/NVL2. Structure, 25, 762-772.E4.
https://doi.org/10.1016/j.str.2017.03.008
|
[31]
|
Li, Y., Zhou, Y., Li, B., et al. (2020) WDR74 Modulates Melanoma Tumorigenesis and Metastasis through the RPL5- MDM2-P53 Pathway. Oncogene, 39, 2741-2755. https://doi.org/10.1038/s41388-020-1179-6
|
[32]
|
Cai, Z., Mei, Y., Jiang, X. and Shi, X.F. (2021) WDR74 Pro-motes Proliferation and Metastasis in Colorectal Cancer Cells through Regulating the Wnt/β-Catenin Signaling Pathway. Open Life Sciences, 16, 920-929.
https://doi.org/10.1515/biol-2021-0096
|
[33]
|
Wang, C., Li, H., Wu, L., et al. (2021) Coiled-Coil Do-main-Containing 68 Downregulation Promotes Colorectal Cancer Cell Growth by Inhibiting ITCH-Mediated CDK4 Degradation. Frontiers in Oncology, 11, Article 668743.
https://doi.org/10.3389/fonc.2021.668743
|
[34]
|
Assi, T., Kattan, J., Rassy, E., et al. (2020) Targeting CDK4 (Cy-clin-Dependent Kinase) Amplification in Liposarcoma: A Comprehensive Review. Critical Reviews in Oncolo-gy/Hematology, 153, Article ID: 103029.
https://doi.org/10.1016/j.critrevonc.2020.103029
|
[35]
|
Carvajal, R.D., Tse, A. and Schwartz, G.K. (2006) Aurora Kinases: New Targets for Cancer Therapy. Clinical Cancer Research, 12, 6869-6875. https://doi.org/10.1158/1078-0432.CCR-06-1405
|
[36]
|
Liu, F., Zhang, Y., Dong, Y., et al. (2021) Knockdown of AURKA Sensitizes the Efficacy of Radiation in Human Colorectal Cancer. Life Sciences, 271, Article ID: 119148. https://doi.org/10.1016/j.lfs.2021.119148
|
[37]
|
Casorzo, L., Dell’aglio, C., Sarotto, I., et al. (2015) Aurora kinase A Gene Copy Number Is Associated with the Malignant Transformation of Colorectal Adenomas but Not with the Serrated Neoplasia Progression. Human Pathology, 46, 411-418. https://doi.org/10.1016/j.humpath.2014.11.016
|
[38]
|
Shan, B., Zhao, R., Zhou, J., et al. (2020) AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by In-hibiting the TP53-Mediated DNA Damage Response Genes. BioMed Research International, 2020, Article ID: 8916729. https://doi.org/10.1155/2020/8916729
|
[39]
|
Li, X., Wu, Y., Hui, D., et al. (2021) Multiple Bronchiolar Adenomas with Malignant Transformation and CCNE1 Mutation: A Case Report and Literature Review. Journal of Cardiothoracic Surgery, 16, Article No. 307.
https://doi.org/10.1186/s13019-021-01687-5
|